avalglucosidase alfa-ngpt
avalglucosidase alfa-ngpt is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Nexviazyme. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- avalglucosidase alfa-ngpt
- Brand Names
- Nexviazyme
- Application Number
- BLA761194
- Sponsor
- Genzyme Corporation
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- AVALGLUCOSIDASE ALFA
Indications and Usage
1 INDICATIONS AND USAGE NEXVIAZYME is indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). NEXVIAZYME is a hydrolytic lysosomal glycogen-specific enzyme indicated for the treatment of patients 1 year of age and older with late-onset Pompe disease (lysosomal acid alpha-glucosidase [GAA] deficiency). ( 1 )